Table 2.
Temporal Changes in Echocardiographic Parameters During Treatment by Anthracyclines, Taxanes, and Trastuzumab
Before Treatment | Postanthracyclines (3 Mo) | 6 Mo | 9 Mo | 12 Mo | End of Treatment | |
---|---|---|---|---|---|---|
LVEF, % | 64 ± 5 | 62 ± 5* | 59 ± 5† | 58 ± 5† | 58 ± 6† | 59 ± 6† |
Longitudinal strain, % | 21 ± 2 | 19 ± 2† | 18 ± 3† | 18 ± 3† | 19 ± 2† | 19 ± 2† |
Radial strain, % | 53 ± 15 | 50 ± 17* | 43 ± 16‡ | 37 ± 16‡ | 34 ± 16† | 41 ± 17‡ |
Circumferential strain, % | 18 ± 4 | 16 ± 4‡ | 15 ± 3‡ | 15 ± 3‡ | 15 ± 3‡ | 16 ± 3§ |
LVEF indicates left ventricular ejection fraction.
The analysis was performed using an ANOVA for repeated measurements on 69 patients with complete follow-up.
P<0.03;
P<0.0001;
P<0.005;
P<0.001 vs before treatment.